Medication-induced hyperlipoproteinemia

Medication-induced hyperlipoproteinemia
Medication-induced hyperlipoproteinemia
Specialty	Dermatology

Medication-induced hyperlipoproteinemia is a condition that results from the decreasing of lipoprotein lipase activity resulting in eruptive xanthomas.^[1]^: 535

References

^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.

This cutaneous condition article is a stub. You can help Wikipedia by expanding it.

[Andrews-1] James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.

[1]

Medication-induced hyperlipoproteinemia

See also

References